TSND-201

DRUG2 trials

Sponsors

Transcend Therapeutics

Conditions

Post Traumatic Stress Disorder

Phase 3

An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)

RecruitingNCT07456696

Transcend TherapeuticsPost Traumatic Stress Disorder

Start: 2026-04-02End: 2027-12-01Target: 300Updated: 2026-09-17

An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSD

Enrolling by invitationNCT07670702

Transcend TherapeuticsPost Traumatic Stress Disorder

Start: 2026-06-22End: 2029-01-01Target: 300Updated: 2026-09-04